{
  "pmcid": "6996094",
  "sha256": "f3b78b8dc98a91498c74cecd613a6b9be78595c3ca7054782c37f78c80552b0d",
  "timestamp_utc": "2025-11-09T22:52:51.474071+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.465733225108227,
    "reading_ease": 31.40431412337665,
    "word_count": 231
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Title: Randomised Controlled Trial of Deep Brain Stimulation for Treatment-Resistant Depression"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "This randomised controlled trial included 25 patients with TRD"
      },
      "Participants": {
        "score": 2,
        "evidence": "25 patients with TRD recruited from two hospitals in the Netherlands. Participants met criteria for major depressive disorder and had failed multiple treatment steps."
      },
      "Intervention": {
        "score": 2,
        "evidence": "All patients underwent DBS surgery and entered a 1-year optimisation phase followed by a 1-year open-label maintenance phase."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to evaluate the efficacy and safety of DBS targeted at the ventral anterior limb of the internal capsule (vALIC) in TRD patients."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the response rate (â‰¥50% HAM-D-17 score reduction) after the maintenance phase."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 3,
        "evidence": "1-year open-label maintenance phase"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "This randomised controlled trial included 25 patients with TRD"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Of the 25 patients, 21 entered and 18 completed the maintenance phase."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Eight patients were classified as responders (observed response rate: 44.4%; intention-to-treat: 32.0%)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Four serious adverse events occurred, none related to DBS."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NTR2118."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 19,
    "max_score": 25
  }
}